10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
GILEAD SCIENCES, INC. | |||
Ticker: GILD Fiscal Year: 2014 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 25, 2015) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Revenues [Abstract] | |||
| Product sales | $ 24,474 | 10,804 | 9,398 |
| Royalty, contract and other revenues | 416 | 398 | 304 |
| Total revenues | 24,890 | 11,202 | 9,702 |
| Costs and Expenses [Abstract] | |||
| Cost of goods sold | 3,788 | 2,859 | 2,471 |
| Research and development expenses | 2,854 | 2,120 | 1,760 |
| Selling, general and administrative expenses | 2,983 | 1,699 | 1,461 |
| Total costs and expenses | 9,625 | 6,678 | 5,692 |
| Income from operations | 15,265 | 4,524 | 4,010 |
| Interest expense | (412) | (307) | (361) |
| Other income (expense), net | 3 | (9) | (37) |
| Income before provision for income taxes | 14,856 | 4,208 | 3,612 |
| Provision for income taxes | 2,797 | 1,151 | 1,038 |
| Net income | 12,059 | 3,057 | 2,574 |
| Net loss attributable to noncontrolling interest | 42 | 18 | 18 |
| Net income attributable to Gilead | 12,101 | 3,075 | 2,592 |
| Net income per share attributable to Gilead common stockholdersbasic | 7.95 | 2.01 | 1.71 |
| Shares used in per share calculationbasic | 1,522 | 1,529 | 1,515 |
| Net income per share attributable to Gilead common stockholdersdiluted | 7.35 | 1.81 | 1.64 |
| Shares used in per share calculationdiluted | 1,647 | 1,695 | 1,583 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2014 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |